MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/hjh.0000000000003132

Медицинская библиотека · Journal of hypertension · 2022

11C-Metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a prospective clinical trial.

Puar Troy H, Khoo Chin Meng, Tan Colin Jingxian, Tong Aaron Kian Ti, Tan Michael Chien Sheng, Teo Ada Ee Der, Ng Keng Sin, Wong Kang Min, Reilhac Anthonin, O'Doherty Jim, Gomez-Sanchez Celso E, Kek Peng Chin, Yee Szemen, Tan Alvin W K, Chuah Matthew Bingfeng, Lee Daphne Hui Min, Wang Kuo Weng, Zheng Charles Qishi, Shi Luming, Robins Edward George, Foo Roger Sik Yin, for the PA CURE investigators

Клиническое исследованиеСтатьяVideo-Audio MediaПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

Adrenal vein sampling (AVS) is recommended to subtype primary aldosteronism, but it is technically challenging. We compared 11C-Metomidate-PET-computed tomography (PET-CT) and AVS for subtyping of primary aldosteronism.

METHODS

Patients with confirmed primary aldosteronism underwent both AVS and 11C-Metomidate PET-CT (post-dexamethasone). All results were reviewed at a multidisciplinary meeting to decide on final subtype diagnosis. Primary outcome was accuracy of PET versus AVS to diagnosis of unilateral primary aldosteronism based on post-surgical biochemical cure. Secondary outcome was accuracy of both tests to final subtype diagnosis.

RESULTS

All 25 patients recruited underwent PET and successful AVS (100%). Final diagnosis was unilateral in 22 patients, bilateral in two and indeterminate in one due to discordant lateralization. Twenty patients with unilateral primary aldosteronism underwent surgery, with 100% complete biochemical success, and 75% complete/partial clinical success. For the primary outcome, sensitivity of PET was 80% [95% confidence interval (95% CI): 56.3-94.3] and AVS was 75% (95% CI: 50.9-91.3). For the secondary outcome, sensitivity and specificity of PET was 81.9% (95% CI: 59.7-94.8) and 100% (95% CI: 15.8-100), and AVS was 68.2% (95% CI: 45.1-86.1) and 100% (95% CI: 15.8-100), respectively. Twelve out of 20 (60%) patients had both PET and AVS lateralization, four (20%) PET-only, three (15%) AVS-only, while one patient did not lateralize on PET or AVS. Post-surgery outcomes did not differ between patients identified by either test.

CONCLUSION

In our pilot study, 11C-Metomidate PET-CT performed comparably to AVS, and this should be validated in larger studies. PET identified patients with unilateral primary aldosteronism missed on AVS, and these tests could be used together to identify more patients with unilateral primary aldosteronism.

VIDEO ABSTRACT: http://links.lww.com/HJH/B918.

Для цитирования: Puar Troy H, Khoo Chin Meng, Tan Colin Jingxian, Tong Aaron Kian Ti, Tan Michael Chien Sheng, Teo Ada Ee Der, Ng Keng Sin, Wong Kang Min, Reilhac Anthonin, O'Doherty Jim, Gomez-Sanchez Celso E, Kek Peng Chin, Yee Szemen, Tan Alvin W K, Chuah Matthew Bingfeng, Lee Daphne Hui Min, Wang Kuo Weng, Zheng Charles Qishi, Shi Luming, Robins Edward George, Foo Roger Sik Yin, for the PA CURE investigators. 11C-Metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a prospective clinical trial.. Journal of hypertension. 2022. DOI: 10.1097/hjh.0000000000003132.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.